This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
AJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA — Description, Dosage, Side Effects | PillsCard
OTC
AJOVY 225 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
INN: AJOVY
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇪🇸🇫🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Teva Gmbh (ES)
Source
CIMA_ES
USDailyMed:Fremanezumab
AU:B1
N02CD03(WHO)
AU:S4(Prescription only)CA:℞-only/ Schedule DUK:US:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only)
1655501-53-3
DB14041
none
PF8K38CG54
D11055
Fremanezumab, sold under the brand nameAjovy, is amedicationused to preventmigraines.It is given bysubcutaneous injection(injection under the skin).
The most common side effect is pain and redness at the site of injection.Other side effects include allergic reactions.It is acalcitonin gene-related peptide antagonist.
It was approved for medical use in the United States in 2018,the European Union in 2019,the United Kingdom in 2020,and Argentina by September 2021.